Evidence map›Paper›PMID 33544320›Full record

ArticleAnnals of nuclear medicine2021

Diagnostic value of [

Jan Jamsek, Marko Hocevar, Damijan Bergant, Katja Zaletel, Sebastijan Rep, Luka Lezaic

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of nuclear medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Application of theranostics in thyroid cancer management.The Journal of clinical endocrinology and metabolism · 2026
    Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jan JamsekDepartment of Nuclear Medicine, University Medical Centre Ljubljana, Zaloska cesta 7, 1000, Ljubljana, Slovenia.ORCID https://orcid.org/0000-0002-6323-8767
Marko HocevarDepartment of Surgical Oncology, Institute of Oncology, Zaloska cesta 2, 1000, Ljubljana, Slovenia.
Damijan BergantDepartment of Surgical Oncology, Institute of Oncology, Zaloska cesta 2, 1000, Ljubljana, Slovenia.
Katja ZaletelDepartment of Nuclear Medicine, University Medical Centre Ljubljana, Zaloska cesta 7, 1000, Ljubljana, Slovenia.
Sebastijan RepDepartment of Nuclear Medicine, University Medical Centre Ljubljana, Zaloska cesta 7, 1000, Ljubljana, Slovenia.
Luka LezaicDepartment of Nuclear Medicine, University Medical Centre Ljubljana, Zaloska cesta 7, 1000, Ljubljana, Slovenia. luka.lezaic@kclj.si.ORCID http://orcid.org/0000-0002-1341-403X
University of Ljubljana · SIInstitute of Oncology Ljubljana · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMedullary thyroid cancer (MTC) is a challenging neuroendocrine malignancy where the role of nuclear medicine imaging is currently limited. This paper investigates the potential diagnostic value of [

methodsWe prospectively enrolled 25 patients (10 male, 15 female) with suspicion for primary MTC based on fine-needle aspiration biopsy (FNAB). All patients had a baseline three phase [

resultsNineteen of 25 patients (76%) were surgically treated and histopathology reports were obtained. Patient-based sensitivity and positive predictive value for detection of any MTC lesion using [

conclusion[

Indexed as

AdultAgedAged, 80 and overBiological TransportCalcitoninCarcinoma, NeuroendocrineCholineFemaleFluorine RadioisotopesHumansMaleMediastinumMiddle AgedNeckPositron Emission Tomography Computed TomographyProspective StudiesCalcitoninCholineFluorine-18Fluorine Radioisotopesfluorocholine[18F]FluorocholineCancer stagingMedullary thyroid cancerNeck-USPET/CT

Identifiers

PMID33544320
OpenAlexW3126670082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.